175 related articles for article (PubMed ID: 15314520)
61. Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists.
McIntosh J; Sturpe DA; Khanna N
J Am Pharm Assoc (2003); 2008; 48(1):e1-13; quiz e14-7. PubMed ID: 18192123
[TBL] [Abstract][Full Text] [Related]
62. Therapeutic vaccination against human papilloma virus induced malignancies.
van der Burg SH; Melief CJ
Curr Opin Immunol; 2011 Apr; 23(2):252-7. PubMed ID: 21237632
[TBL] [Abstract][Full Text] [Related]
63. New advances in vaccine technology and improved cervical cancer prevention.
Huh WK; Kendrick JE; Alvarez RD
Obstet Gynecol; 2007 May; 109(5):1187-92. PubMed ID: 17470604
[TBL] [Abstract][Full Text] [Related]
64. Estimating the long-term clinical impact of cervical cancer vaccination in Taiwan.
Yen MS; You SL; Ferko N; Debicki D; Chen YC; Chou CY
Int J Gynecol Cancer; 2009 Feb; 19(2):281-8. PubMed ID: 19396010
[TBL] [Abstract][Full Text] [Related]
65. Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.
Vici P; Pizzuti L; Mariani L; Zampa G; Santini D; Di Lauro L; Gamucci T; Natoli C; Marchetti P; Barba M; Maugeri-Saccà M; Sergi D; Tomao F; Vizza E; Di Filippo S; Paolini F; Curzio G; Corrado G; Michelotti A; Sanguineti G; Giordano A; De Maria R; Venuti A
Expert Rev Vaccines; 2016 Oct; 15(10):1327-36. PubMed ID: 27063030
[TBL] [Abstract][Full Text] [Related]
66. Developments in therapeutic human papillomavirus vaccination.
Albers AE; Siniković B; Banko AV; Jovanović S; Kaufmann AM
Acta Chir Iugosl; 2009; 56(3):29-37. PubMed ID: 20218099
[TBL] [Abstract][Full Text] [Related]
67. Immunologic treatments for precancerous lesions and uterine cervical cancer.
Vici P; Mariani L; Pizzuti L; Sergi D; Di Lauro L; Vizza E; Tomao F; Tomao S; Cavallotti C; Paolini F; Venuti A
J Exp Clin Cancer Res; 2014 Mar; 33(1):29. PubMed ID: 24667138
[TBL] [Abstract][Full Text] [Related]
68. Immunotherapy for gynaecological malignancies.
Coukos G; Conejo-Garcia JR; Roden RB; Wu TC
Expert Opin Biol Ther; 2005 Sep; 5(9):1193-210. PubMed ID: 16120050
[TBL] [Abstract][Full Text] [Related]
69. Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
Zhang Y; Liu S; Chen M; Ou Q; Tian S; Tang J; He Z; Chen Z; Wang C
BMC Cancer; 2024 Mar; 24(1):288. PubMed ID: 38439023
[TBL] [Abstract][Full Text] [Related]
70. Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy.
Ruzzi F; Semprini MS; Scalambra L; Palladini A; Angelicola S; Cappello C; Pittino OM; Nanni P; Lollini PL
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629147
[TBL] [Abstract][Full Text] [Related]
71. Therapeutic Vaccine Strategies against Human Papillomavirus.
Khallouf H; Grabowska AK; Riemer AB
Vaccines (Basel); 2014 Jun; 2(2):422-62. PubMed ID: 26344626
[TBL] [Abstract][Full Text] [Related]
72. New Approaches to Immunotherapy for HPV Associated Cancers.
Bergot AS; Kassianos A; Frazer IH; Mittal D
Cancers (Basel); 2011 Sep; 3(3):3461-95. PubMed ID: 24212964
[TBL] [Abstract][Full Text] [Related]
73. HPV - immune response to infection and vaccination.
Stanley M
Infect Agent Cancer; 2010 Oct; 5():19. PubMed ID: 20961432
[TBL] [Abstract][Full Text] [Related]
74. Immunotherapeutic strategies for cervical squamous carcinoma.
van Driel WJ; Kenter GG; Fleuren GJ; Melief CJ; Trimbos BJ
Hematol Oncol Clin North Am; 1999 Feb; 13(1):259-73. PubMed ID: 10080080
[TBL] [Abstract][Full Text] [Related]
75. Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention.
Haldar SD; Vilar E; Maitra A; Zaidi N
Cancer Prev Res (Phila); 2023 Sep; 16(9):483-495. PubMed ID: 37001882
[TBL] [Abstract][Full Text] [Related]
76. Nanoparticle-based applications for cervical cancer treatment in drug delivery, gene editing, and therapeutic cancer vaccines.
Zhou P; Liu W; Cheng Y; Qian D
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1718. PubMed ID: 33942532
[TBL] [Abstract][Full Text] [Related]
77. Vaccination-Based Immunoprevention of Colorectal Tumors: A Primer for the Clinician.
Jackson K; Samaddar S; Markiewicz MA; Bansal A
J Clin Gastroenterol; 2023 Mar; 57(3):246-252. PubMed ID: 36730670
[TBL] [Abstract][Full Text] [Related]
78. A review of the research progress in T-lymphocyte immunity and cervical cancer.
Zhang L; Mao Z; Lai Y; Wan T; Zhang K; Zhou B
Transl Cancer Res; 2020 Mar; 9(3):2026-2036. PubMed ID: 35117549
[TBL] [Abstract][Full Text] [Related]
79. Prospects for human papillomavirus vaccine development: emerging HPV vaccines.
Hines JF; Ghim S; Jenson AB
Curr Opin Infect Dis; 1998 Feb; 11(1):57-61. PubMed ID: 17033369
[TBL] [Abstract][Full Text] [Related]
80. [Therapeutic cancer vaccination for treatment of haematological cancers].
Holmström MO; Grauslund JH; Dahlager-Jørgensen NG; Klausen U; Hasselbalch HC; Andersen MH
Ugeskr Laeger; 2019 Oct; 181(20A):. PubMed ID: 31610839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
